Medibank Private (MPL) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
10 Nov, 2026Resident policyholder growth
FY23 industry policyholder growth expected at ~2% vs 2.7% in FY22; Adult Dependent Reform estimated to reduce growth by ~0.4%, with no impact on hospital lives.
FYTD resident policyholder growth was 0.4k, or 0.02%, as at 31 Mar 23; outlook was 0.5%–0.75% for FY23, assuming recent trends continue.
Retained an additional ~18k adult dependents; service NPS recovered above benchmark levels in both brands, and lapse intent returned to pre-cybercrime levels.
Expect a strong Q4 and a further customer give-back before 30 Jun 23.
Non-resident growth
FYTD policy unit growth was 62.0k to 258.5k as at 31 Mar 23, including 28.6k growth in the three months to March; on track for the highest joins in five years.
Student, worker and visitor visa segments rebounded; working visas exceeded pre-COVID levels, with international student arrivals and digital joins supporting growth.
FY23 non-resident gross profit expected to approximately double from FY22, with a similar PHI gross margin benefit to 1H23.
Health care models and partnerships
No-gap joint replacement program available locally to 65% of members; ~4% of joint replacement procedures used the short-stay model, versus 2.2% in FY21.
Short-stay joint replacement had NPS of 71 versus 55.2 for standard care, ~ $1.4k episode savings, and a 50% lower average hospital stay; estimated total costs were $24k–$27k versus $30k–$33k.
Hospital contracting approach spans partnership, value-based and base-indexation contracts, representing 55%, 24% and 21% of episodes, respectively; priorities include customer outcomes, value and system efficiency.
Aurora Healthcare JV plans to invest $31m across three hospitals, adding 153 mental health beds and out-of-hospital support.
Latest events from Medibank Private
- Underlying NPAT rose 13.8% in 1H25 as private health insurance growth continued.MPL
Corporate presentation - Prevention, integrated care and targeted investment underpin Amplar Health’s expansion.MPL
Investor presentation - 1H26 profit growth supports FY30 ambitions for health earnings, market share and engagement.MPL
Corporate presentation - Operating profit up 6.7%, with 31.3% health segment growth and higher dividends.MPL
H2 2026 - Operating profit up 6%, Medibank Health profit up 28.5%, and interim dividend up 6.4%.MPL
H1 2026 - Strong financial results, board renewal, and ambitious health sector growth plans defined the AGM.MPL
AGM 2025 - Health earnings to exceed AUD 200 million and engagement to reach 10 million by FY30.MPL
Status Update - Strong financials, higher dividends, and board expansion marked this year's AGM.MPL
AGM 2024 - Underlying NPAT up 13.8% and dividend up 8.3% amid strong growth and resilient capital.MPL
H1 2025